MAPT and Alzheimer disease: The negative age association likely reflects a combination of more pure and aggressive AD pathology in younger AD Dementia participants (Gerritsen et al., 2016) and less age-related co-pathology in younger patients, which would then require greater levels of tau burden to reach a similar level of impairment compared with their older counterparts.